Tools


Home > Seminars, events & talks


Seminars, events & talks

Friday, 27th April, 2018, 12.00:13.00

Computational Biophysics

Understanding Complex Systems Using High-Dimensional Neural Network Potentials

Speaker: Jörg Behler, Theoretical Chemistry Institute of Physical Chemistry, Georg-August-University Göttingen, Germany

Room Xipre (1st Floor, 173.06-183.01), PRBB Building

Friday, 13th April, 2018, 11:00 - 12:00

Computational Biophysics

Artificial intelligence: From predictions to sequential decision making

Speaker: Anders Jonsson, AI&ML Research group, Information and Communication Technologies Dep, UPF

Room Xipre (1st Floor, 173.06-183.01), PRBB Building

Friday, 22th September, 2017, 11:00 - 12:00

Computational Biophysics

Molecular simulation methods for ensemble-based drug design

Speaker: Julien Michel, Royal Society University Research Fellow, School of Chemistry Joseph Black Building, University of Edinburgh

Room Xipre (173.06-183.01), PRBB Building

Friday, 10th March, 2017, 11:00-12:00

Computational Biophysics

Structural prediction of protein-protein interactions for the upcoming challenges in biomedicine

Speaker: Juan Fernández Recio, Research Director, BSC.

Room Ramón y Cajal Room, PRBB Building

Friday, 20th January, 2017, 13.00 - 14.00

Computational Biophysics

Protein dynamics and molecular design: computational approaches with an eye to chemical biology

Speaker: Giorgio Colombo, Instituto di Chimica del Riconoscimento Molecolare, CNR, Italia​,

Room ​ Xipre Room (Seminar ​173.06-183.01), PRBB Building

Thursday, 15th September, 2016, 12.30 - 13.30

Computational Biophysics

Redesigning Drug Design of kinase inhibitors

Drug design lags far behind other engineering disciplines in lacking predictive, quantitative models that allow small-molecule therapeutics to be designed, rather than fortuitously discovered. While many challenges exist to building these models, our laboratory uses cycles of computational predictions coupled to experimental measurements to rapidly generate data that can be used to improve rigorous, quantitative approaches to small molecule design based on alchemical free energy calculations.  In this talk, we describe how this process can be done cheaply in an automated manner by inverting the drug discovery problem, and describe our first few steps toward this goal in the design of selective kinase inhibitors.
 

Speaker: John Chodera, Assistant Faculty Member, Computational Biology Memorial Sloan-Kettering Cancer Center, NYC, USA

Room Xipre Room (173.06-183.01), PRBB Building

Friday, 29th April, 2016, 11.00 - 12.00

Computational Biophysics

Incremental Unsupervised Training of Deep Architectures

After a brief introduction to deep architectures and their typical supervised and unsupervised training approaches, the talk focuses on incremental strategies (at the base of natural learning). We will present our experience on incremental training of both CNN (Convolutional Neural Networks) and HTM (Hierarchical Temporal Memory). In particular a recently proposed semi-supervised tuning strategy (exploiting time coherence) proved to be very effective in conjunction with HTM, sometimes approaching supervised training accuracy.

Speaker: Davide Maltoni, University of Bologna (Dept. of Computer Science and Engineering - DISI)

Room Xipre Seminar (173.06)

Friday, 26th February, 2016, 11.00-12.00

Computational Biophysics

Deep Neural Networks and Reinforcement Learning for Building Intelligent Machines.

The goal of Artificial Intelligence (AI) is to build machines that can display complex behavior, such as for example reaching human level performance in some tasks. The Machine Learning approach to achieve this goal is to provide the machine with a powerful mathematical framework and data from which complex behaviors can be learned. In this talk, I will introduce deep neural networks and reinforcement learning, which are considered two of the most promising mathematical frameworks solving difficult tasks in many different domains, and discuss their strengths and challenges.

Speaker: Dr. Silvia Chiappa, Senior Researcher at Google Deep Mind, UK.

Room Charles Darwin Room

Thursday, 5th November, 2015, 12.00-13.00

Computational Biophysics

The Virtual Human: In Silico Methods for Personalised Medicine

The era of personalised medicine offers at once a huge opportunity and a major challenge to computational science. The potential impact centres around our ability to marshall substantial quantities of patient data and to use them to perform predictive, mechanistic modelling and simulation in order to deliver therapies and to enhance clinical decision making, on time scales which are far shorter than those usually considered in the context of academic research and development activities. Secure access to personal data, as well as to powerful computational resources, is essential. I shall provide a couple of examples which illustrate the current state of the art. One addresses clinical decision support in the context of blood flow within neurovascular pathologies; the other is concerned with patient specific drug discovery and treatment. We shall discuss the underlying e-infrastructure requirements, including data, compute and networks, and reflect on the potential for cloud and other forms of e-infrastructure provision to meet the anticipated future demand for resources.

Speaker: Peter V. Coveney, Department of Chemistry, UCL.

Room Charles Darwin Room

Wednesday, 3rd December, 2014, 12.00-13.00

Computational Biophysics

Rational design of antibodies targeting intrinsically disordered proteins

In biological systems nearly all processes are governed by interactions between protein molecules, which have evolved to perform an innumerable variety of functions. The ability of some proteins, such as antibodies, to interact with high affinity and specificity is being increasingly exploited for therapeutic and diagnostic applications. Yet, using current methods it is laborious and often difficult to generate antibodies against specific epitopes within a protein, in particular within disordered regions. Likewise, the successful development of antibody-based drugs is often hindered by their relatively poor solubility, which leads to aggregation at the high concentrations necessary for effective storage and delivery. 
I will present two computational approaches to rationally modify interactions between protein molecules, including antibodies. The aim of the first is to hamper aberrant interactions by predicting mutations that improve the solubility, while retaining native state and activity. Its application to a single-domain antibody demonstrates that solubility changes upon mutation are estimated with great accuracy, thus offering a cost-effective strategy for the production of soluble proteins. The second consists in the rational design of protein-protein interactions by engineering a scaffold to bind to virtually any target disordered epitope in a protein. We validate this method by designing five single domain antibodies to bind different epitopes within three disease-related intrinsically disordered proteins (α-synculein, Aβ and IAPP). The results show that all antibodies bind to their target with good affinity and specificity. As an example of an application we carried out further experiments on one of these antibodies to show that it inhibits the aggregation of α-synuclein at low substoichiometric concentrations, and that binding indeed occurs at the selected epitope.

Speaker: Pietro Sormanni, PhD Student, Department of Chemistry, University of Cambridge, Cambridge

Room Aula room (470.03 – 4th floor)



Site Information